Expansion Of Clinical Trials Is Fueling Market Growth Due To Increasing Demand For Drug Safety Assessment: The Driving Engine Behind Pharmaceutical Safety Assessment Market Evolution in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Pharmaceutical Safety Assessment Market Size Growth Forecast: What to Expect by 2025?
Strong expansion has characterized the pharmaceutical safety assessment market recently, with its valuation set to increase from $10.47 billion this year, 2024, to $11.32 billion come 2025, reflecting an 8.1% compound annual growth rate over that span; this historical upward trajectory is largely fueled by an increased need for preclinical investigations, escalating mandates concerning drug security, a trend toward utilizing contract research organizations for outsourced work, progress in developing animal testing methodologies, and the quicker integration of in vitro cell-based testing techniques.

How Will the Pharmaceutical Safety Assessment Market Size Evolve and Grow by 2029?
Anticipated robust expansion characterizes the future trajectory of the pharmaceutical safety assessment industry, projecting a market valuation reaching $15.64 billion by 2029, propelled by a compound annual growth rate of 8.4% throughout the forecast duration; this upward momentum is chiefly fueled by the proliferation of biologics and biosimilars, the greater incorporation of in-silico toxicology platforms, heightened capital outlay directed towards personalized medicine initiatives, a regulatory pivot favoring non-animal testing methodologies, and escalating necessity for high-throughput screening apparatus.

View the full report here:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-safety-assessment-global-market-report

What Drivers Are Propelling the Growth of Pharmaceutical Safety Assessment Market Forward?
The ongoing augmentation of clinical trials is widely anticipated to be the catalyst for the expansion observed in the pharmaceutical safety assessment market. Clinical trials inherently involve scientific investigations conducted with human subjects designed to scrutinize the efficacy, security, and untoward results associated with novel pharmaceutical agents or medical procedures. This upward trend in trials stems from an increasing demand for novel and more potent therapeutic options, reflecting the commitment of medical investigators and practitioners to formulate interventions capable of superior disease prevention, mitigation, or eradication. These crucial studies underpin the pharmaceutical safety evaluation process by methodically examining a compound's influence on people via rigorously overseen experiments, tracking unwanted outcomes, establishing appropriate tolerance levels, and furnishing the critical evidence upon which governing bodies rely to confirm that medicines are both beneficial and secure for broader societal utilization. To illustrate this point, data cited by the National Library of Medicine (NLM), an American repository for biomedical literature, indicated that as of September 26, 2025, ClinicalTrials.gov hosted the registration of 554,798 ongoing studies. Consequently, the escalation in clinical research activities directly fuels the progression of the pharmaceutical safety assessment industry.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=29147&type=smp

Which Emerging Trends Are Transforming the Pharmaceutical Safety Assessment Market in 2025?
Leading entities operating within the pharmaceutical safety evaluation sector are prioritizing the creation of artificial intelligence fueled decision-making aids aimed at boosting both the precision and swiftness associated with forecasting adverse effects and establishing safety profiles. These AI-based decision support systems represent software frameworks leveraging machine learning capabilities to examine diverse datasets and furnish valuable intelligence, thereby facilitating more rapid and precise choices. Illustratively, in April of 2024, US-headquartered life sciences firm Charles River Laboratories, in collaboration with Ireland-based Deciphex, an organization driving enhanced diagnostic accuracy and rapidity via AI-directed quality assurance, introduced the Patholytix Foresight system, an AI-driven decision support instrument engineered to revolutionize toxicologic pathology within pharmaceutical safety evaluations. This new platform employs artificial intelligence techniques to expedite the examination of intricate preclinical pathology information, which in turn aids in the earlier detection of potential hazards and minimizes subjective interpretation of outcomes. Its distinctive capabilities encompass an AI algorithm specifically built for identifying abnormalities in tissues, a globally accessible, cloud-hosted architecture supporting worldwide partnership, and a flexible architecture engineered to decrease the duration required for slide review while simultaneously elevating the dependability and uniformity of accumulated data.

What Are the Key Segments in the Pharmaceutical Safety Assessment Market?
The pharmaceutical safety assessmentmarket covered in this report is segmented -

1) By Type: In-Vitro Safety Assessment, In-Vivo Safety Assessment, Computational Safety Assessment
2) By Drug Type: Biological Drugs, Chemical Drugs
3) By Phase: Preclinical, Clinical (Phase I, II, III), Post-Market Surveillance (Phase IV)
4) By End User: Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Academic And Research Institutions, Contract Research Organizations (CROs)

Subsegments:
1) By In-Vitro Safety Assessment: Cell-Based Assays, Organotypic Models, Tissue Culture Models, High-Throughput Screening
2) By In-Vivo Safety Assessment: Rodent Studies, Non-Rodent Studies, Toxicokinetic Studies, Carcinogenicity Studies
3) By Computational Safety Assessment: Quantitative Structure-Activity Relationship (QSAR) Modeling, Physiologically Based Pharmacokinetic (PBPK) Modeling, Toxicity Prediction Software, In Silico Simulation Studies

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=29147&type=smp

Who Are the Key Players Shaping the Pharmaceutical Safety Assessment Market's Competitive Landscape?
Major companies operating in the pharmaceutical safety assessment market are IQVIA Holding Inc., LabCorp (formerly Covance), Thermo Fisher Scientific (PPD), Charles River Laboratories, ICON plc, Parexel International Corp., Syneos Health, Eurofins Scientific SE, Wuxi Biologics Inc., SGS SA, Medpace Holdings Inc., Fujifilm Wako (Fujifilm Corp.), Pharmaron Beijing Co. Ltd., Inotiv (incl. Envigo), Evotec (Cyprotex), Intertek Group, Altasciences Inc., Aragen Life Sciences Ltd., CTI Clinical Trial and Consulting Inc., ChemDiv Inc., Frontage Laboratories, Medicilon Inc., Biotoxtech Co. Ltd., BioIVT, Accelera Srl.

What Geographic Markets Are Powering Growth in the Pharmaceutical Safety Assessment Market?
North America was the largest region in the pharmaceutical safety assessment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the the pharmaceutical safety assessment market market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=29147

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.